Corporate and Other comprises administrative expenses for central Group functions that cannot be directly allocated to the business sectors.
Key figures |
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
Change |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
€ million |
|
2024 |
|
2023 |
|
€ million |
|
% |
||||||
Operating result (EBIT)1 |
|
-702 |
|
-713 |
|
11 |
|
-1.5% |
||||||
EBITDA2 |
|
-584 |
|
-603 |
|
19 |
|
-3.2% |
||||||
EBITDA pre1 |
|
-482 |
|
-397 |
|
-85 |
|
21.4% |
||||||
|
||||||||||||||
The improvement in the operating result and EBITDA in fiscal 2024 in comparison with the previous year resulted in particular from a reduction in expenses in connection with a program to continuously improve processes and align the enabling Group functions more closely with the businesses. This decrease was partly offset by higher ongoing administrative expenses, which led to a decline in EBITDA pre. Cross-business research and development costs amounting to € 92 million (2023: € 94 million) were allocated to Corporate and Other.